Key result
AMPD1 C34T genotype is unlinked to athlete status but associated with ~13% more rugby playing time.
Why the study?
Adenosine monophosphate deaminase deficiency has been implicated in impaired exercise capacity, prompting examination of whether the AMPD1 C34T genotype associates with athlete status and performance.
Does the AMPD1 C34T genotype influence athlete status and physical performance in elite distance runners and rugby union athletes?
Cross-Sectional (n=2,316)
Does the AMPD1 C34T genotype influence athlete status and physical performance in elite distance runners and rugby union athletes?
The AMPD1 C34T genotype is not associated with athlete status but may influence specific performance metrics such as playing time in rugby and run times in elite distance runners.
No takes yet. Share an insight, caveat, or question.
Should not guide athlete selection or training; leaves open AMPD1 C34T role in DR and RU performance.
Martin et al. (2026) conducted a cross-sectional in Athlete status and physical performance (n=2,316). AMPD1 C34T (rs17602729) genotype vs. Non-athletes or alternative genotypes was evaluated on Athlete status and physical performance metrics. The AMPD1 C34T genotype was not associated with athlete status, but the CC genotype was associated with 13% greater playing time in rugby forwards and the CT genotype with up to 5% faster run times.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: